Biotech pigment maker Octarine Bio secures new funding
23/01/2026
Danish biotech company Octarine Bio has raised a further €5 million, bringing its total Series A funding round to €12.8. A new investor in the company includes DSM-Firmenich Ventures, a sign of possible applications in cosmetics, and continued support from former Novozymes executives, early day supporters of the start-up. The new funds will...
Share this story:
